 Tranexamic acid treatment hemothorax patients malignant mesothelioma Patients malignant mesothelioma hemothorax combination oral intrapleural tranexamic acid patients severe complication Initiation treatment potent anti-fibrinolytic drug rapid reduction transfusion requirements